The Green Organic Dutchman (TSX:TGOD) Stock Continues to Fall in October

Is there more mayhem in store for The Green Organic Dutchman shareholders after a 40% fall in October?

Shares of The Green Organic Dutchman (TSX:TGOD) fell over 3.3% on October 21, 2019. The stock is currently trading at $1.15, which is 80% below its 52-week high of $5.81. TGOD has almost 45% in market value this month and has burnt significant investor wealth.

TGOD investors have become increasingly wary of the stock ever since Aurora Cannabis sold its 10.5% stake in the company last month. On October 9, TGOD’s management also announced that it is struggling to raise debt capital on favourable terms resulting in a significant sell-off of company stock.

TGOD’s press release had then stated, “As previously disclosed, the company had been engaged in discussions for ordinary course commercial bank facilities and equipment leasing.

However, because of changing market conditions, those sources of financing have been unavailable on acceptable terms within the time frames required, leading the company to commence a review of additional alternatives.”

But if TGOD is unable to raise the required capital, it will have to revise the construction schedule of its licensed facilities at Ancaster and Valleyfield. TGOD’s Ancaster facility is close to competition and has supply agreements with Canadian provinces of Ontario, Alberta and British Columbia.

TGOD announced that debt capital will also be used ramp up production and build its product portfolio to be ready for cannabis 2.0. Cannabis-infused edibles, vapes, and concentrates will be available for retail purchase starting December 16, 2019.

Several cannabis companies are finding it difficult to raise debt funding from U.S.-based banks, as cannabis is still illegal at the federal level, and as a result, banks are unwilling to pump in millions of dollars.

TGOD will cut its capital expenditure

TGOD stock has been trading lower over the last two days after the company unveiled a strategic plan to reduce financing requirements and grow profitability as it continues to look for capital.

The company believes these plans will lower capital expenditure and result in optimal production capacity. TGOD is optimistic about achieving positive cash flow by the second quarter of fiscal 2020 (year ending in July).

It also stated that the Ancaster greenhouse is complete while the processing facility is five weeks away from completion. TGOD’s Valleyfield facility will be “demarcated into smaller phases, with more to be completed once the market further develops.”

These two facilities will increase TGOD production between 20,000 kilograms and 22,000 kilograms of cannabis in 2020. TGOD has also employed a strategic advisor to evaluate funding options and raise between $70 million and $80 million.

There’s a good chance that TGOD will have to dig into operating cash flow to fund its projects. It also claimed that it can raise funds after proven sales from the Ancaster facility. TGOD has attributed the lower capex forecast to the slow rollout of retail locations in major Canadian provinces — this forecast sent cannabis stocks lower on Friday.

The company like several other cannabis peers seems to have overestimated the legal marijuana market, which is struggling with cannibalization from illegal sellers.

TGOD ready for cannabis 2.0

TGOD has announced that it’s ready to commercialize cannabis-infused products such as organic teas, vapes and others by mid-December. It’s working with several co-packers to launch liquid beverages and topicals in 2020 after Health Canada licenses these facilities.

Will TGOD’s race to profitability result in a boost in stock price? Well, the company first needs to move closer to operating profitability in the October quarter to keep investors interested.

Analysts remain optimistic about TGOD stock with a 12-month price target of $3.28 for the stock, which is 185% above the current trading price.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Aurora Cannabis (TSX:ACB) is one stock that could wipe out your nest egg.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Here’s Why I Wouldn’t Touch Canopy Growth Stock With a 10-Foot Pole

Down almost 99% from all-time highs, Canopy Growth is a beaten-down cannabis stock that remains a high-risk investment in 2026.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

2 Stocks That Could Turn $100,000 Into $0 Faster Than You Think

Canopy Growth and Plug Power are two unprofitable stocks that remain high-risk investments for shareholders in 2026.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Will Canopy Growth Keep the Losing Streak Going in 2026?

Canopy Growth Corp (TSX:WEED) was one of the market's biggest losers in 2025.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »